The stock's fall snapped a three-day winning streak.

Abbott (ABT) ended the recent trading session at $114.12, demonstrating a -1.92% change from the preceding day's closing price. This move lagged the S&P 500's daily gain of 0.04%. Meanwhile, the Dow ...

"Boring" may be just what the doctor ordered in this volatile market.

You may not immediately recognize the name Abbott Laboratories (NYSE: ABT), but you've probably come into close contact with one of the company's many products -- from a coronavirus test to Ensure ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Abbott Laboratories (NYSE:ABT) ...

Abbott Laboratories' (NYSE: ABT) January 2026 price pullback is making its stock look attractively valued. The move, driven more by market angst and fear than by any real weaknesses, seems to be a ...

Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) fell 8.3% in the afternoon session after the company reported fourth-quarter revenue that missed Wall Street's ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Abbott Laboratories (NYSE: ABT) will release its fiscal fourth-quarter earnings report next Thursday before the opening bell, setting up an intriguing idea for bullish options traders. Ordinarily, ABT ...

Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.

This company has delivered earnings and dividend growth over time. Abbott’s innovation and a new acquisition could spur more growth in the years to come. 10 stocks we like better than Abbott ...